TNFRSF10B

Across TCGA pan-cancer cohorts, TNFRSF10B Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TNFRSF10B data layer compared with 25 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher TNFRSF10B Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TNFRSF10B expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

KIRP, HNSC, and UCEC are the cancer types where TNFRSF10B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.037	0.920	<.001	24	view →
HNSC	OS	Median	All	0.069	0.768	<.001	24	view →
UCEC	DFS	Median	All	1.000	0.627	.018	14	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TNFRSF10B–KIRP (DFS)

Open the KIRP breakdown →